Ian Lobley

Corporate Officer/Principal chez 3I GROUP PLC

Profil

Ian Matthew Lobley is currently a Non-Executive Director at EUSA Pharma, Inc. since 2010, a Non-Executive Director at The British Standards Institution since 2019, a Director at Tato Holdings Ltd., a Director at A.E.S.
Engineering Ltd. since 2013, a Director at Cirtec Medical Systems LLC, a Non-Executive Director at Jazz Pharmaceuticals UK Ltd., Managing Partner-Asset Management at 3i Group Plc since 1987, and Managing Partner at 3i Private Equity since 1987.
Former roles include Independent Non-Executive Director at 3i Infrastructure Plc from 2014 to 2023, Director at DiBcom SA, Non-Executive Director at Psytechnics Ltd., Non-Executive Director at Intense Ltd., Director at CRF Box Oy, Director at The Cloud Networks Ltd., Non-Executive Director at Nujira Ltd., Non-Executive Director at Power Integrations U.K.
Ltd., Director at Netronome Systems, Inc., Senior Independent Director at BSI Group Ltd., and Board Observer at ACR Capital Holdings Pte.
Ltd. from 2014 to 2020.
Education includes undergraduate studies at the University of Birmingham.

Postes actifs de Ian Lobley

Sociétés	Poste	Début
3I GROUP PLC	Corporate Officer/Principal	01/01/1987
3i Private Equity	Private Equity Investor	01/10/1987
Tato Holdings Ltd.	Directeur/Membre du Conseil	-
Cirtec Medical Systems LLC	Directeur/Membre du Conseil	-
The British Standards Institution	Directeur/Membre du Conseil	01/05/2019
A.E.S. Engineering Ltd.	Directeur/Membre du Conseil	18/09/2013
Jazz Pharmaceuticals UK Ltd.	Directeur/Membre du Conseil	-
EUSA Pharma, Inc.	Directeur/Membre du Conseil	21/01/2010

Anciens postes connus de Ian Lobley

Sociétés	Poste	Fin
3I INFRASTRUCTURE PLC	Directeur/Membre du Conseil	20/07/2023
░░░ ░░░░░░░ ░░░░░░░░ ░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░ ░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-
░░░ ░░░░░ ░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-